V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240014362 | 240008590 | null | 91 | Curative (C) | 2016-01-18 | 2016-04-18 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 240004276 | ABVD R |
| 240014363 | 240012592 | null | 99.2 | Palliative (P) | 2017-04-28 | 2017-05-02 | R-PMitCEBOM | N | N | 240004286 | CHLORAMBUCIL + OBINUTUZUMAB |
| 240014364 | 240012593 | 1.64 | null | Curative (C) | 2018-06-05 | 2018-06-05 | IVE | 2 | null | 240004510 | TOPOTECAN |
| 240014365 | 240012595 | 1.57 | 73.2 | Disease modification (D) | 2017-12-05 | 2017-12-10 | AML 18 TRIAL | N | N | 240004667 | BEACOPP |
| 240014366 | 240012597 | 1.82 | 77 | Disease modification (D) | 2016-05-16 | 2016-06-18 | GEMCITABINE + VINORELBINE | N | N | 240004839 | DOCETAXEL |
| 240014367 | 240015905 | null | null | Disease modification (D) | 2013-08-11 | 2013-10-02 | Ifosfamide | Y | N | 240005033 | CVD |
| 240014368 | 240008603 | 0 | 107.8 | Curative (C) | 2014-07-12 | 2014-07-24 | CHLORAMBUCIL + DEXAMETHASONE + DEXAMETHASONE + ETOPOSIDE | N | N | 240005082 | R-EPOCH |
| 240014369 | 240008608 | 1.61 | 61.8 | Curative (C) | 2018-01-11 | 2018-01-11 | GEMTUZUMAB OZOGAMICIN | 2 | N | 240005364 | CISPLATIN + GEMCITABINE |
| 240014370 | 240016152 | null | 69.3 | Not known (9) | 2013-10-22 | 2013-10-24 | IDELALISIB | 02 | N | 240005553 | NORDIC |
| 240014371 | 240016152 | 1.66 | 75.7 | Curative (C) | 2015-10-12 | 2015-10-18 | Ixazomib + Lenalidomide | N | N | 240005553 | GEMTUZUMAB OZOGAMICIN |
| 240014372 | 240008613 | 1.54 | 56 | Curative (C) | 2014-08-07 | 2014-09-17 | Cytarabine HD + Methotrexate HD | N | N | 240005841 | DOXORUBICIN |
| 240014373 | 240008614 | 1.75 | 68 | Curative (C) | 2017-04-05 | 2017-04-05 | IDELALISIB | N | N | 240005884 | CLADRIBINE |
| 240014374 | 240008616 | 1.52 | 54.6 | Disease modification (D) | 2018-03-05 | 2018-07-02 | CARBOPLATIN + EPIRUBICIN + PACLITAXEL | N | N | 240006269 | AML18 TRIAL |
| 240014375 | 240008618 | 1.66 | 98 | Palliative (P) | 2017-02-13 | 2017-01-11 | REMODLB TRIAL | N | null | 240006303 | CARBOPLATIN + LIPOSOMAL DOX |
| 240014376 | 240008619 | 1.85 | 83 | Neo-adjuvant (N) | 2014-08-13 | 2014-08-14 | PMitCEBO-R | 02 | null | 240006338 | PMITCEBO-R |
| 240014377 | 240008621 | 1.71 | 51 | Palliative (P) | 2015-05-13 | 2015-05-15 | DHAP - R | N | N | 240006383 | GALLIUM TRIAL |
| 240014378 | 240008624 | 1.68 | 52.6 | Curative (C) | 2017-09-05 | 2017-09-12 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 240006577 | OFATUMUMAB |
| 240014379 | 240008627 | 1.58 | 44.8 | Palliative (P) | 2018-11-29 | 2019-06-11 | Gemcitabine + Vinorelbine IV | 02 | N | 240006614 | R-EPOCH |
| 240014380 | 240008628 | 1.64 | 51 | Palliative (P) | 2015-06-27 | 2015-06-27 | Temozolomide 200mg/m2 | N | N | 240007017 | IPILIMUMAB + NIVOLUMAB |
| 240014381 | 240008630 | 1.71 | 68.7 | Palliative (P) | 2016-08-22 | 2016-08-29 | AML 19 TRIAL | 2 | N | 240007170 | GEMCITABINE + PACLITAXEL |
| 240014382 | 240008632 | 1.77 | 77.5 | Palliative (P) | 2017-11-18 | 2017-11-26 | Cytarabine intrathecal | N | Y | 240007284 | UKALL2014 |
| 240014383 | 240008634 | 1.78 | 135 | Palliative (P) | 2017-02-15 | 2017-02-15 | Gemcitabine + Oxaliplatin | N | N | 240007399 | R-EPOCH |
| 240014384 | 240008639 | 1.84 | null | Palliative (P) | 2016-03-31 | 2016-04-01 | IVAC | 02 | N | 240007447 | R-EPOCH |
| 240014385 | 240012614 | 1.59 | 59.9 | Curative (C) | 2019-02-02 | 2019-04-06 | DA-EPOCH-R | null | null | 240007531 | VEDEX |
| 240014386 | 240008640 | 1.66 | null | Disease modification (D) | 2016-03-27 | 2016-04-03 | Sorafenib | null | null | 240007767 | TRIFLURIDINE + TIPIRACIL |
| 240014387 | 240008643 | 1.71 | 80.6 | Curative (C) | 2017-08-04 | 2017-11-28 | Etoposide IV | N | N | 240007918 | BEVACIZUMAB + CARBO |
| 240014388 | 240016153 | 1.55 | 64.35 | Palliative (P) | 2019-09-20 | 2019-09-20 | AML16 DA 3+8 | null | N | 240007996 | IMATINIB |
| 240014389 | 240008645 | 1.64 | null | Palliative (P) | 2019-03-19 | 2019-03-26 | Erlotinib | 02 | null | 240008056 | CAPECITABINE + OXALIPLATIN |
| 240014390 | 240014489 | 1.7 | 57 | Curative (C) | 2015-04-23 | 2015-04-28 | DHAP - R | 02 | N | 240008149 | RCD TRIAL |
| 240014391 | 240008648 | 1.76 | 77.1 | Disease modification (D) | null | 2018-06-14 | FLAG | 02 | N | 240008265 | IVE |
| 240014392 | 240014490 | 0 | 66.7 | Disease modification (D) | 2016-04-18 | 2016-04-20 | CISPLATIN + FLUOROURACIL | 2 | N | 240008306 | TRABECTEDIN |
| 240014393 | 240008653 | 1.63 | 48.4 | Curative (C) | 2017-11-16 | 2018-05-30 | ALL UKALL60+ TRIAL | Y | null | 240008316 | CARBOPLATIN + DOCETAXEL |
| 240014394 | 240008655 | 0 | 62.5 | Curative (C) | null | 2018-08-29 | Clofarabine + Cytarabine | N | N | 240008385 | IVE |
| 240014395 | 240008657 | null | 0 | Adjuvant (A) | 2015-08-12 | 2016-03-31 | Doxorubicin 75mg/m2 | 02 | N | 240008463 | CARBOPLATIN + VINORELBINE |
| 240014396 | 240008660 | 1.57 | 96.8 | Palliative (P) | 2016-06-27 | 2016-07-01 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | 240008494 | DOXORUBICIN |
| 240014397 | 240012624 | null | 0 | Palliative (P) | 2014-10-30 | 2014-10-30 | AML18 PILOT TRIAL | 2 | N | 240008658 | CYTARABINE + RITUXIMAB |
| 240014398 | 240008665 | 1.53 | 49.7 | Palliative (P) | 2016-01-07 | 2016-01-07 | ESHAP R | N | N | 240008732 | CYTARABINE INTRATHECAL |
| 240014399 | 240008667 | 1.7 | 96.3 | Disease modification (D) | null | 2014-01-12 | MATRIX (lymphoma) | 02 | N | 240008851 | ICE-R |
| 240014400 | 240008670 | null | null | Curative (C) | 2016-04-13 | 2016-04-16 | VINCRISTINE | N | N | 240009028 | VEDEX |
| 240014401 | 240012629 | null | null | Palliative (P) | 2015-06-28 | 2015-10-17 | Y-90 | 2 | null | 240009295 | IMATINIB |
| 240014402 | 240015427 | 1.64 | 70.8 | Curative (C) | 2018-03-08 | 2018-03-21 | ICE (no GCSF) | 2 | null | 240009443 | AML19 TRIAL |
| 240014403 | 240008676 | 1.71 | 61.8 | Curative (C) | 2017-03-25 | 2017-03-25 | ESHAP R | N | N | 240009614 | ICE-R |
| 240014404 | 240008679 | 1.76 | 77.1 | Palliative (P) | 2017-04-23 | 2017-04-29 | IDELALISIB | N | null | 240009661 | BCG |
| 240014405 | 240008684 | 1.65 | 81.5 | Palliative (P) | 2016-01-29 | 2016-02-19 | Erlotinib | N | N | 240009723 | CTD |
| 240014406 | 240015912 | 1.74 | 77 | Curative (C) | 2018-07-02 | 2018-09-26 | IVE | N | N | 240009728 | OFATUMUMAB |
| 240014407 | 240015912 | 1.54 | 85.4 | Palliative (P) | 2016-09-01 | 2017-06-26 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 240009728 | TOPOTECAN |
| 240014408 | 240014496 | null | 57.8 | Palliative (P) | 2015-04-10 | 2015-05-15 | Sorafenib | null | N | 240009959 | CARBOPLATIN + RT |
| 240014409 | 240008688 | 1.62 | 66.5 | Disease modification (D) | 2015-05-07 | 2015-06-03 | CYTARABINE + ETOPOSIDE | 02 | N | 240009989 | CYCLOPHOSPHAMIDE + DOCETAXEL + TRASTUZUMAB |
| 240014410 | 240008690 | null | null | Palliative (P) | null | 2018-08-22 | PIXANTRONE | null | null | 240010015 | DHAP - R |
| 240014411 | 240008692 | 1.84 | 55 | Not known (9) | 2018-06-03 | 2018-07-30 | BENDAMUSTINE + OFATUMUMAB | N | N | 240010103 | CYTARABINE + RITUXIMAB |